Metformin

"Metformin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)

Descriptor ID	D008687
MeSH Number(s)	D02.078.370.141.450
Concept/Terms	Metformin Metformin Dimethylbiguanidine Dimethylguanylguanidine Glucophage Glucophage Metformin Hydrochloride Metformin Hydrochloride Hydrochloride, Metformin Metformin HCl HCl, Metformin

Below are MeSH descriptors whose meaning is more general than "Metformin".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Amidines [D02.078]
Guanidines [D02.078.370]
Biguanides [D02.078.370.141]
Metformin [D02.078.370.141.450]

Below are MeSH descriptors whose meaning is related to "Metformin".

Below are MeSH descriptors whose meaning is more specific than "Metformin".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Metformin" by people in this website by year, and whether "Metformin" was a major or minor topic of these publications.

Bar chart showing 60 publications over 23 distinct years, with a maximum of 6 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	1	1	2
2003	0	1	1
2005	1	0	1
2006	1	1	2
2008	1	0	1
2009	2	0	2
2010	3	1	4
2011	1	0	1
2012	0	1	1
2013	2	1	3
2014	3	1	4
2015	1	3	4
2016	1	0	1
2017	1	1	2
2018	3	2	5
2019	5	1	6
2020	1	0	1
2021	3	1	4
2022	2	0	2
2023	3	0	3
2024	1	1	2
2025	5	0	5
2026	2	1	3

Below are the most recent publications written about "Metformin" by people in Profiles.

Rossouw J, Wallis R, Kornfeld H, Singhal A, Maartens G, Wiesner L, Denti P, Wasmann RE. The effect of metformin on the pharmacokinetics of rifampicin, isoniazid, and pyrazinamide in adults with tuberculosis. Antimicrob Agents Chemother. 2026 Sep 02; 70(9):e0074826.

View in: PubMed
Wilkie G. Type 2 Diabetes in Pregnancy: Management and Novel Therapies. Clin Obstet Gynecol. 2026 Jun 01; 69(2):203-209.

View in: PubMed
Rodrigues A, Sweigert E, Robinson D, Kregel M, Williamson J, Koehler A, Schreckengast S, Forry C, Loeven K, Puffenberger E, McVey A, Hendrickson C, Patel A, Thomas A, Thomas S, Brigatti KW, Strauss K, Meier GL. Metformin therapy to facilitate weight loss in adults with classic maple syrup urine disease. Mol Genet Metab. 2026 Mar; 147(3):109730.

View in: PubMed
Cashman TJ, Saheera S, Blau AE, Mensah Otabil E, Nagy NY, Samenuk TD, Fitzgibbons TP, McManus DD, Trivedi CM. Epigenetic dysregulation of energy homeostasis drives aortic valve stenosis that is treatable with metformin. JCI Insight. 2025 09 09; 10(17).

View in: PubMed
Bramante CT, Stewart TG, Boulware DR, McCarthy MW, Gao Y, Rothman RL, Mourad A, Thicklin F, Cohen JB, Garcia Del Sol IT, Ruiz-Unger J, Shah NS, Mehta M, Cardona OQ, Scott J, Ginde AA, Castro M, Jayaweera D, Sulkowski M, Gentile N, McTigue K, Felker GM, Collins S, Dunsmore SE, Adam SJ, Lindsell CJ, Hernandez AF, Naggie S. Metformin and Time to Sustained Recovery in Adults With COVID-19: The ACTIV-6 Randomized Clinical Trial. JAMA Intern Med. 2025 09 01; 185(9):1092-1101.

View in: PubMed
Arian CM, O'Mahony ET, Manwill PK, Graf TN, Oberlies NH, Cech NB, Clarke JD, Smith JG, Paine MF, Kelly EJ, Thummel KE. A gut response: Application of human enteroid monolayers to probe the mechanism of the goldenseal-mediated inhibition of metformin intestinal absorption. J Pharmacol Exp Ther. 2025 Jun; 392(6):103597.

View in: PubMed
Hasanvand A, Ghandinezhad M, Nourmohammadi M, Hatami F, Beiranvand B, Haghighatian Z, Amanolahi Baharvand P, Kharazmkia A. Investigating the role of the AMPK signaling pathway in preventing CCI-induced neuropathy in rats: focus on anti-inflammatory effects. Neurol Res. 2025 Jun; 47(6):494-503.

View in: PubMed
Wilkie G, Payne A, Baltich Nelson B, Whelan AR. Early gestational diabetes mellitus and the effect of metformin use on perinatal outcomes: a systematic review. Minerva Obstet Gynecol. 2025 Jun; 77(3):215-218.

View in: PubMed
Sawalha K, Gautam N, Sivakumar K, Paydak H, Mehta JL. Metformin: Its salutary effects beyond diabetes mellitus. J Investig Med. 2025 06; 73(5):363-375.

View in: PubMed
Chen F, Mangano KM, Garelnabi M, Cardaleen K, Tucker KL. Associations among diabetes medication use, serum magnesium, and insulin resistance in a cohort of older Puerto Rican adults. Am J Clin Nutr. 2024 06; 119(6):1523-1532.

View in: PubMed

People

Explore

Similar Concepts

Top Journals